TruAlt Bioenergy Ltd

TruAlt Bioenergy Ltd

Initial public offering of up to [*] equity shares of face value of Rs. 10 each ("Equity Shares") of Trualt Bioenergy Limited (The "Company" or the "Company" or the "Issuer") for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) (the "Offer Price") aggregating up to Rs. [*] crores (the "Offer") comprising a fresh issue of up to [*] equity shares of face value of Rs. 10 each by the company aggregating up to Rs. 750.00 crores (the "Fresh Issue") and an offer for sale of up to 36,00,000 equity shares of face value of Rs. 10 each aggregating up to Rs. [*] crores, comprising an offer for sale of up to 18,00,000 equity shares of face value of Rs. 10 each aggregating up to Rs. [*] crores by Dhraksayani Sangamesh Nirani, and up to 18,00,000 equity shares of face value of Rs. 10 each aggregating up to Rs. [*] crores by Sangamesh Rudrappa Nirani (collectively, the "Selling Shareholders", and each individually, as a "Selling Shareholder" and such offer for sale of equity shares by the selling shareholders, the "Offer for Sale"). The offer will constitute [*]% of the post-offer paid-up equity share capital of the company. The company, in consultation with the brlms, may consider a private placement, rights issue, preferential offer or any other method of specified securities as may be permitted under applicable laws, to any person(s), for an aggregate amount not exceeding Rs. 150.00 crores ("pre-ipo placement"), with the roc. The pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. If the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to the offer complying with rule 19(2)(b) of the scrr. The pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. Prior to the completion of the offer, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer or the offer may be successful and will result into listing of the equity shares on the stock exchanges. Further, relevant disclosures in relation to such intimation to the subscribers of the pre-ipo placement (if undertaken) shall be appropriately made in the relevant sections of the red herring prospectus and the prospectus. The price band and the minimum bid lot will be decided by the company.